|
tbar.gif
Click
here to
submit entries
|
|
|
More
Deaths Possibly Linked to Baxter’s Heparin
|
February
29, 2008--The
FDA said the number of deaths possibly associated with Baxter
International’s brand of heparin had risen to 21 from 4. Baxter expanded
a recall to include virtually all of its heparin products. The FDA has yet
to identify the root cause of the problem, and has not concluded that the
Chinese plant which supplied much of the active ingredient for Baxter’s
heparin was responsible. The
New York Times (Free registration required)
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
